The Venture Codex Logo

The Venture Codex

Overview

Founder-focused seed-stage venture capital firm.

Founded

2022

Deals ยท 12mo

2

Stage focus

Seed
Series A

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Life Science
Therapeutics

Investment portfolio

4rounds
NAMEDATESIZE
R1 Therapeutics
Sep 2026Participated
$3 MSeries A
R1 Therapeutics
Mar 2026Participated
$78 MSeries A
Tesseract Medical Research
Jun 2024Led
$20 MSeed
Differentiated Therapeutics
Aug 2022Led
$5 MSeed
R1 Therapeutics
Sep 2026Participated
$3 MSeries A
R1 Therapeutics
Mar 2026Participated
$78 MSeries A
Tesseract Medical Research
Jun 2024Led
$20 MSeed
Differentiated Therapeutics
Aug 2022Led
$5 MSeed
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Curie.Bio: 4 funding rounds are recorded in the selected participation categories.All available history.
Curie.Bio: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series A02

Monthly Deal Activity

Curie.Bio: 4 deals are recorded across 51 months.All available history.
Curie.Bio: 4 deals are recorded across 51 months. All available history
MonthDeals
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Curie.Bio: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Curie.Bio: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Consumer & Lifestyle1

Deal Size Distribution

Curie.Bio: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Curie.Bio: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M1
$10M-$25M1
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Curie.Bio: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Curie.Bio: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Curie.Bio: 8 co-investors are shown, with Abingworth sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Curie.Bio: 8 co-investors are shown, with Abingworth sharing 2 recorded deals. All available history
Co-investorShared deals
Abingworth2
DaVita Venture Group2
F-Prime Capital2
U.S. Renal Care2
Chengwei Capital1
Samsara BioCapital1
SNMA Capital1
SymBiosis1

Investment Strategy

Curie.Bio: Led accounts for 50% and participating for 50% of round participation.All available history.
Curie.Bio: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led250%
Participating250%
Curie.Bio: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Curie.Bio: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Alexis A. Borisy

Co-Founder & Chairman

Ben Auspitz

Director

Chris De Savi

CSO Partner

Christoph Lengauer

Co-Founder and CSO

Zach Weinberg

Co-Founder and CEO